2020: The Year of TRUE Convergence of TECH+BIOTECH+MEDTECH in Healthcare

This is NOT another COVID event, but a look at how the global pandemic has changed the way life science companies operate, make deals and keep their technologies moving forward. It is also a look at how TECH+BIOTECH+MEDTECH have converged at an accelerated pace and what it might mean for the future of healthcare.

The speakers will share their deep knowledge of how the pandemic has altered the life sciences landscape, clinical development and deal-making, and how technology is rapidly being applied to healthcare solutions.

Learn more about our TECH+BIOTECH+MEDTECH community and other upcoming events here.

Moderated By:

Matthew Hudes, CEO, bdlBiologx

Featuring:

Marianne De Backer, Head of Pharmaceuticals Business Development & Licensing, Bayer

Regis Kelly, Director, QB3

Rachael Lester, VP Corporate Development, Harpoon Therapeutics

Gail Maderis, President & CEO, Antiva Biosciences

Bo Saxberg, President, DDO Strategic Services, LLC